S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Dell Technologies breaks out ahead of earnings release
AI Stock Caught Trading Under Secret Name (Ad)
Dropbox’s stock is a falling knife worth catching
Novavax’s dispute resolution and upcoming earnings call
AI Stock Caught Trading Under Secret Name (Ad)
Stock ideas from the 2024 Microcap Conference
Warner Bros. Discover: Debt down, profits up, yet questions remain
AI Stock Caught Trading Under Secret Name (Ad)
Gloom settles over Germany's economy, with businesses downbeat about the coming months
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Dell Technologies breaks out ahead of earnings release
AI Stock Caught Trading Under Secret Name (Ad)
Dropbox’s stock is a falling knife worth catching
Novavax’s dispute resolution and upcoming earnings call
AI Stock Caught Trading Under Secret Name (Ad)
Stock ideas from the 2024 Microcap Conference
Warner Bros. Discover: Debt down, profits up, yet questions remain
AI Stock Caught Trading Under Secret Name (Ad)
Gloom settles over Germany's economy, with businesses downbeat about the coming months
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Dell Technologies breaks out ahead of earnings release
AI Stock Caught Trading Under Secret Name (Ad)
Dropbox’s stock is a falling knife worth catching
Novavax’s dispute resolution and upcoming earnings call
AI Stock Caught Trading Under Secret Name (Ad)
Stock ideas from the 2024 Microcap Conference
Warner Bros. Discover: Debt down, profits up, yet questions remain
AI Stock Caught Trading Under Secret Name (Ad)
Gloom settles over Germany's economy, with businesses downbeat about the coming months
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Dell Technologies breaks out ahead of earnings release
AI Stock Caught Trading Under Secret Name (Ad)
Dropbox’s stock is a falling knife worth catching
Novavax’s dispute resolution and upcoming earnings call
AI Stock Caught Trading Under Secret Name (Ad)
Stock ideas from the 2024 Microcap Conference
Warner Bros. Discover: Debt down, profits up, yet questions remain
AI Stock Caught Trading Under Secret Name (Ad)
Gloom settles over Germany's economy, with businesses downbeat about the coming months
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024

iRhythm Technologies (IRTC) Stock Price, News & Analysis

$105.07
-10.00 (-8.69%)
(As of 02/23/2024 ET)
Today's Range
$104.01
$110.97
50-Day Range
$100.25
$123.61
52-Week Range
$70.24
$140.23
Volume
1.15 million shs
Average Volume
336,193 shs
Market Capitalization
$3.22 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$135.38

iRhythm Technologies MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
28.6% Upside
$135.11 Price Target
Short Interest
Healthy
4.18% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.03mentions of iRhythm Technologies in the last 14 days
Based on 39 Articles This Week
Insider Trading
Selling Shares
$745,692 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($3.39) to ($2.49) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.12 out of 5 stars

Medical Sector

590th out of 941 stocks

Surgical & Medical Instruments Industry

68th out of 90 stocks


IRTC stock logo

About iRhythm Technologies Stock (NASDAQ:IRTC)

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

IRTC Stock Price History

IRTC Stock News Headlines

Irhythm Technologies: Poised for Growth Despite Challenges
Better Than Oil Stocks
The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment. 
Recap: iRhythm Technologies Q4 Earnings
Better Than Oil Stocks
The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment. 
IRTC Jun 2024 100.000 call
IRTC Apr 2024 120.000 put
iRhythm Investor Deadline Approaching
iRhythm Ongoing Deadline Alert
IRTC Jun 2024 110.000 put
See More Headlines
Receive IRTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/04/2021
Today
2/24/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:IRTC
Fax
N/A
Employees
1,793
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$135.11
High Stock Price Target
$165.00
Low Stock Price Target
$110.00
Potential Upside/Downside
+28.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
8 Analysts

Profitability

Net Income
$-116,150,000.00
Pretax Margin
-22.07%

Debt

Sales & Book Value

Annual Sales
$410.92 million
Book Value
$7.96 per share

Miscellaneous

Free Float
30,519,000
Market Cap
$3.22 billion
Optionable
Optionable
Beta
1.33
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report














IRTC Stock Analysis - Frequently Asked Questions

Should I buy or sell iRhythm Technologies stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for iRhythm Technologies in the last year. There are currently 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" IRTC shares.
View IRTC analyst ratings
or view top-rated stocks.

What is iRhythm Technologies' stock price target for 2024?

8 brokers have issued twelve-month target prices for iRhythm Technologies' stock. Their IRTC share price targets range from $110.00 to $165.00. On average, they expect the company's stock price to reach $135.11 in the next year. This suggests a possible upside of 28.6% from the stock's current price.
View analysts price targets for IRTC
or view top-rated stocks among Wall Street analysts.

How have IRTC shares performed in 2024?

iRhythm Technologies' stock was trading at $107.04 on January 1st, 2024. Since then, IRTC shares have decreased by 1.8% and is now trading at $105.07.
View the best growth stocks for 2024 here
.

Are investors shorting iRhythm Technologies?

iRhythm Technologies saw a increase in short interest in the month of January. As of January 31st, there was short interest totaling 1,280,000 shares, an increase of 11.3% from the January 15th total of 1,150,000 shares. Based on an average daily volume of 340,400 shares, the short-interest ratio is presently 3.8 days.
View iRhythm Technologies' Short Interest
.

When is iRhythm Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our IRTC earnings forecast
.

How were iRhythm Technologies' earnings last quarter?

iRhythm Technologies, Inc. (NASDAQ:IRTC) posted its earnings results on Thursday, November, 4th. The company reported ($0.81) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.09) by $0.28. The company had revenue of $85.43 million for the quarter, compared to analysts' expectations of $83.65 million. iRhythm Technologies had a negative trailing twelve-month return on equity of 46.35% and a negative net margin of 22.19%. The company's revenue was up 18.7% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.17) earnings per share.

What guidance has iRhythm Technologies issued on next quarter's earnings?

iRhythm Technologies issued an update on its FY 2024 earnings guidance on Monday, January, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $575.0 million-$585.0 million, compared to the consensus revenue estimate of $489.2 million.

What is Kevin M. King's approval rating as iRhythm Technologies' CEO?

20 employees have rated iRhythm Technologies Chief Executive Officer Kevin M. King on Glassdoor.com. Kevin M. King has an approval rating of 91% among the company's employees. This puts Kevin M. King in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of iRhythm Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iRhythm Technologies investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Block (SQ), Teladoc Health (TDOC), Trade Desk (TTD), Advanced Micro Devices (AMD), Intel (INTC), Broadcom (AVGO) and Boeing (BA).

When did iRhythm Technologies IPO?

(IRTC) raised $76 million in an IPO on Thursday, October 20th 2016. The company issued 5,400,000 shares at $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

Who are iRhythm Technologies' major shareholders?

iRhythm Technologies' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (9.77%), Capital Research Global Investors (8.14%), Sands Capital Management LLC (7.30%), Artisan Partners Limited Partnership (6.76%), Mackenzie Financial Corp (4.13%) and Fiera Capital Corp (1.30%). Insiders that own company stock include Daniel G Wilson, David A Vort, Douglas Devine, Kevin M King, Mark J Day, Merz Cathleen Noel Bairey, Patrick Michael Murphy and Quentin S Blackford.
View institutional ownership trends
.

How do I buy shares of iRhythm Technologies?

Shares of IRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:IRTC) was last updated on 2/24/2024 by MarketBeat.com Staff